The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy

다국어 초록 (Multilingual Abstract)

Purposes: The aim of our study was to assess the influence of perioperative blood transfusion (PBT) on survival outcomes following radical cystectomy (RC) and pelvic lymph node dissection (PLND).
Materials and Methods: We reviewed and analyzed the clinical data of 432 patients who underwent RC for bladder cancer from 1991 to 2012. PBT was defined as the transfusion of allogeneic red blood cells during RC or postoperative hospitalization.
Results: Of all patients, 315 patients (72.9%) received PBT. On multivariate logistic regression analysis, female gender (p=0.015), a lower preoperative hemoglobin level (p=0.003), estimated blood loss>800 mL (p<0.001), and performance of neoadjuvant chemotherapy (p<0.001) were independent risk factors related to requiring perioperative transfusions. The receipt of PBT was associated with increased overall mortality (hazard ratio, 1.91; 95% confidence interval, 1.25–2.94; p=0.003) on univariate analysis, but its association was not confirmed by multivariate analysis (p=0.058). In transfused patients, a transfusion of >4 packed red blood cell units was an independent predictor of overall survival (p=0.007), but not in cancer specific survival.
Conclusions: Our study was not conclusive to detect a clear association between PBT and survival after RC. However, the efforts should be made to continue limiting the overuse of transfusion especially in patients who are expected to have a high probability of PBT, such as females and those with a low preoperative hemoglobin level and history of neoadjuvant chemotherapy.

참고문헌 (Reference)

1 Acheson AG, "ffects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and metaanalysis" 256 : 235-244, 2012

2 Vamvakas EC, "Transfusion-related immunomodulation (TRIM): an update" 21 : 327-348, 2007

3 Rawn J, "The silent risks of blood transfusion" 21 : 664-668, 2008

4 Morgan TM, "The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer" 31 : 871-877, 2013

5 Gakis G, "The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer" 21 : 428-433, 2011

6 Linder BJ, "The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC)" 114 : 368-374, 2014

7 Linder BJ, "The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy" 63 : 839-845, 2013

8 Gierth M, "The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder" 32 : 1447-1453, 2014

9 De Oliveira GS Jr, "The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer" 22 : 97-103, 2012

10 Corwin HL, "The CRIT Study: Anemia and blood transfusion in the critically ill: current clinical practice in the United States" 32 : 39-52, 2004

11 Saito K, "Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes" 20 : 161-171, 2013

12 Carson JL, "Red blood cell transfusion: a clinical practice guideline from the AABB*" 157 : 49-58, 2012

13 Ito M, "Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel" 78 : 1131-1135, 2011

14 Cross BW, "Preoperative erythrocyte sedimentation rate independently predicts overall survival in localized renal cell carcinoma following radical nephrectomy" 2012 : 524981-, 2012

15 Amato A, "Perioperative blood transfusions for the recurrence of colorectal cancer" (1) : CD005033-, 2006

16 Sutton JM, "Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study" 18 : 1575-1587, 2014

17 Yeoh TY, "Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy" 54 : 2175-2181, 2014

18 Boehm K, "No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer" 2014

19 Komatsu Y, "Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer" 36 : 844-850, 2012

20 Cata JP, "Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions" 110 : 690-701, 2013

21 Kluth LA, "Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder" 113 : 393-398, 2014

22 Moon KC, "External validation of online predictive models for prediction of cancerspecific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder" 21 : 3132-3141, 2014

23 Marik PE, "Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature" 36 : 2667-2674, 2008

24 Kneuertz PJ, "Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma" 18 : 1327-1334, 2011

25 Williams JG, "Effect of perioperative blood transfusion on recurrence of Crohn's disease" 2 : 131-133, 1989

26 Opelz G, "Effect of blood transfusions on subsequent kidney transplants" 5 : 253-259, 1973

27 Monk TG, "Blood conservation strategies to minimize allogeneic blood use in urologic surgery" 170 (170): 69S-73S, 1995

28 Vincent JL, "Anemia and blood transfusion in critically ill patients" 288 : 1499-1507, 2002

29 Chalfin HJ, "Allogeneic versus autologous blood transfusion and survival after radical prostatectomy" 54 : 2168-2174, 2014